Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-043531
Filing Date
2023-05-26
Accepted
2023-05-26 16:17:23
Documents
1
Period of Report
2023-05-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3115
  Complete submission text file 0001213900-23-043531.txt   4756
Mailing Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632
Business Address 560 SYLVAN AVE SUITE 3160 ENGLEWOOD CLIFFS NJ 07632 (718) 400-9031
Silo Pharma, Inc. (Issuer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl

Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address
Ryweck Daniel E. (Reporting) CIK: 0001652799 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41512 | Film No.: 23969146